Title : The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN.

Pub. Date : 2019 Nov 26

PMID : 31725895






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Aberrant JAK2 tyrosine kinase signaling drives the development of Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Tyrosine Janus kinase 2 Homo sapiens